Atopic dermatitis differential diagnosis: Difference between revisions
No edit summary |
|||
(31 intermediate revisions by 5 users not shown) | |||
Line 2: | Line 2: | ||
{{Atopic dermatitis}} | {{Atopic dermatitis}} | ||
{{CMG}}; {{AE}} [[Ogechukwu Hannah Nnabude, MD]]; {{S.S}} | |||
{{CMG}}; {{AE}} | |||
==Overview== | ==Overview== | ||
Atopic dermatitis is a chronic [[inflammatory]] [[skin disorder]], which is indistinguishable from other [[causes]] of dermatitis. Atopic dermatitis is usually associated with personal or [[family history]] of [[atopic diseases]] including [[asthma]], [[allergic rhinitis]] and [[food allergy]]. The most common clinically similar dermatitis in infancy is [[seborrheic dermatitis]] which includes [[hyperkeratosis]] of the [[Scalp rash|scalp]], also found in atopic dermatitis. | |||
== | ==Atopic Dermatitis from other Diseases== | ||
Atopic dermatitis should be differentiated from [[allergic contact dermatitis]], [[iirritant contact dermatitis]], [[seborrheic dermatitis]], [[psoriasis]], [[lichen simplex chronicus]], [[ichthyosis vulgaris]], [[nummular dermatitis (discoid eczema)]], [[netherton's syndrome]], and [[dermatitis herpetiformis]] | |||
{| | {| | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ||
Line 14: | Line 14: | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inherited | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inherited | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ||
! colspan=" | ! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ||
! colspan=" | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="2" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors''' | |||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | |||
! colspan=" | |||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
! colspan=" | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance | ||
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching | ! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Eosinophils | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ||
Line 40: | Line 38: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Involved areas | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Involved areas | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pustule | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pustule | ||
|- | |- | ||
! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Atopic dermatitis | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Epidermal barrier dysfunction | *Epidermal barrier dysfunction | ||
* Immune dysregulation | *[[Immune]] dysregulation | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Incidence is highest during infancy and early childhood. | *[[Incidence]] is highest during [[infancy]] and early childhood. | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*[[Erythema]], [[Exudate|exudates]], [[papules]],[[vesicles]], scales and crusts | *[[Erythema]], [[Exudate|exudates]], [[papules]],[[vesicles]], scales and crusts | ||
* Infiltrated [[erythema]], [[prurigo]], scales and crusts | *Infiltrated [[erythema]], [[prurigo]], scales and crusts | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Young children -Scalp, cheeks amd extensor surface | *Young children -[[Scalp]], [[cheeks]] amd [[extensor]] surface | ||
* Adolescents -flexural areas and buttock-thigh creases | *[[Adolescent|Adolescents]] -flexural areas and buttock-thigh creases | ||
* Adults - facial involvement and skin flexures | *Adults - facial involvement and skin flexures | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Centrofacial pallor | *Centrofacial pallor | ||
* Delayed blanch response | *Delayed blanch response | ||
* [[Keratosis pilaris]] | *[[Keratosis pilaris]] | ||
* Palmar hyperlinearity | *Palmar hyperlinearity | ||
* [[Pityriasis alba]] | *[[Pityriasis alba]] | ||
* [[Ichthyosis]] | *[[Ichthyosis]] | ||
* Infra-auricular and retro-auricular fissuring | *Infra-auricular and retro-auricular fissuring | ||
* Nipple eczema | *Nipple [[eczema]] | ||
* White dermographism | *White dermographism | ||
* Perifollicular accentuation | *Perifollicular accentuation | ||
| align="center" style="background:#F5F5F5;" | Nl to ↑ | | align="center" style="background:#F5F5F5;" |Nl to ↑ | ||
(Eosinophilia) | ([[Eosinophilia|Eosinophilia)]] | ||
| align="center" style="background:#F5F5F5;" |↑ | |||
| align="center" style="background:#F5F5F5;" | ↑ | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Epidermal psoriasiform [[hyperplasia]] | *Epidermal psoriasiform [[hyperplasia]] | ||
* Marked intercellular [[edema]] with spongiotic vesiculation | *Marked intercellular [[edema]] with spongiotic vesiculation | ||
* [[Hyperkeratosis]] | *[[Hyperkeratosis]] | ||
* Psoriasiform hyperplasia | *Psoriasiform [[hyperplasia]] | ||
* Dyskeratosis | *Dyskeratosis | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* | * | ||
* | *[[Family history]] of [[atopic dermatitis]] or other [[atopy]] | ||
*Personal history of [[atopy]] ([[asthma]], [[allergic rhinitis]], [[food allergy]]) | |||
*Active and passive exposure to [[tobacco]] | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Delayed-type hypersensitivity response | *Delayed-type [[hypersensitivity]] response | ||
* Skin inflammation mediated by hapten-specific T cells | *Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |Any | | align="center" style="background:#F5F5F5;" |Any | ||
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure | | align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure | ||
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated papules | | align="center" style="background:#F5F5F5;" |Erythematous well-demarcated [[papules]] | ||
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent | | align="center" style="background:#F5F5F5;" |Surrounding the area in contact with the offending agent | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Stinging and burning | *Stinging and burning | ||
* Localized swelling | *Localized [[swelling]] | ||
* Lichenified pruritic plaques | *[[Lichenification|Lichenified]] [[Itch|pruritic]] [[plaques]] | ||
| align="center" style="background:#F5F5F5;" |Nl to ↑ | | align="center" style="background:#F5F5F5;" |Nl to ↑ | ||
(Eosinophilia) | ([[Eosinophilia]]) | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *[[Eosinophilic]] spongiosis and [[microvesicles]] | ||
*[[Exocytosis]] of [[eosinophils]] and [[lymphocytes]] | |||
*Chronic - [[Hyperkeratosis]] and parakeratosis | |||
| colspan="2" align="center" style="background:#F5F5F5;" | | |||
*Contact with [[allergens]] in the past 1-2 days | |||
*Positive [[family history]] | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Irritant contact dermatitis]]<ref name="pmid30293200">{{cite journal |vauthors=Bains SN, Nash P, Fonacier L |title=Irritant Contact Dermatitis |journal=Clin Rev Allergy Immunol |volume= |issue= |pages= |date=October 2018 |pmid=30293200 |doi=10.1007/s12016-018-8713-0 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Irritant contact dermatitis]]<ref name="pmid30293200">{{cite journal |vauthors=Bains SN, Nash P, Fonacier L |title=Irritant Contact Dermatitis |journal=Clin Rev Allergy Immunol |volume= |issue= |pages= |date=October 2018 |pmid=30293200 |doi=10.1007/s12016-018-8713-0 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Activation of the innate immune system by the pro-inflammatory properties of chemicals | *Activation of the [[innate immune system]] by the pro-[[inflammatory]] properties of chemicals | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |Any, more occupational exposure | | align="center" style="background:#F5F5F5;" |Any, more with occupational exposure | ||
| align="center" style="background:#F5F5F5;" |Usually single immediately after the exposure | | align="center" style="background:#F5F5F5;" |Usually single immediately after the exposure | ||
| align="center" style="background:#F5F5F5;" | Well-demarcated red patch with a glazed surface | | align="center" style="background:#F5F5F5;" |Well-demarcated red patch with a glazed surface | ||
| align="center" style="background:#F5F5F5;" | Any area in contact with the irritant | | align="center" style="background:#F5F5F5;" |Any area in contact with the irritant | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Swelling, blistering and scaling of the damaged area | *[[Swelling]], [[Blister|blistering]] and scaling of the damaged area | ||
* Dryness | *Dryness | ||
* Thicker skin | *Thicker skin | ||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | Nl | |||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Spongiosis | *Spongiosis | ||
* Intraepidermal vesicles or bullae | *Intraepidermal [[vesicles]] or bullae | ||
* Necrosis of keratinocytes | *[[Necrosis]] of [[keratinocytes]] | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Negative hypersensitivity tests | *Cumulative exposure to [[irritants]] | ||
*Negative hypersensitivity tests | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic dermatitis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic dermatitis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Not known | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, onset during the | | align="center" style="background:#F5F5F5;" |Any, onset during the infancy and peak during 3rd-4th decades | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | |||
*[[Cradle cap]] - yellowish scales on the [[Scalp rash|scalp]] | |||
*Patchy or diffuse greasy scaling with or without a yellow-red base | |||
*Crusts | |||
| align="center" style="background:#F5F5F5;" |Scalp, face, trunk, postauricular, diaper area and axilla | |||
| align="center" style="background:#F5F5F5;" | + | |||
| align="center" style="background:#F5F5F5;" | + | |||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | | |||
*Infants: | |||
**[[Cradle cap]] (Sclap) - non-inflammatory greasy scales on the scalp | |||
**Asymptomatic | |||
**Self resolving | |||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Stress | *Focal parakeratosis and spongiosis in epidermis | ||
*Psoriasiform [[hyperplasia]] | |||
*[[Neutrophils]] at the margins | |||
| colspan="2" align="center" style="background:#F5F5F5;" |Risk factors include | |||
*[[Stress]] | |||
* Cold, dry weather | *Cold, dry weather can cause flare ups | ||
*[[Superinfection]] with bacteria and [[candida]] | |||
Generalized seborrheic [[erythroderma]] in immunodeficient patients | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Keratinocyte hyperproliferation | *[[Keratinocyte]] hyperproliferation | ||
* Dysregulation of the immune system | *Dysregulation of the [[immune system]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, 2 peaks of onset 30-39 years and 50-59 years | | align="center" style="background:#F5F5F5;" |Any, 2 peaks of onset 30-39 years and 50-59 years | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" |Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*Scalp | |||
*Trunk | |||
*Gluteal cleft | |||
*Extensor surface of elbows and knees | |||
* Scalp | |||
* Trunk | |||
* Gluteal cleft | |||
* Extensor surface of elbows and knees | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |_ | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | |||
*[[Auspitz's sign]] (pinpoint bleeding) | |||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | | |||
*[[Epidermal]] [[hyperplasia]] | |||
*Parakeratosis | |||
*[[Neutrophils]] microabscesses (Munro microabscesses) | |||
| colspan="2" align="center" style="background:#F5F5F5;" |Risk factors include | |||
*[[Smoking]] | |||
*Skin trauma | |||
*[[Alcohol abuse]] | |||
*[[Stress]] | |||
*Cold weather | |||
*Vitamin D deficiency | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lichen simplex chronicus|Lichen simplex]] <ref name="pmid28785363">{{cite journal |vauthors=Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G |title=Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade |journal=Open Access Maced J Med Sci |volume=5 |issue=4 |pages=556–557 |date=July 2017 |pmid=28785363 |pmc=5535688 |doi=10.3889/oamjms.2017.133 |url=}}</ref>[[Lichen simplex chronicus|chronicus]] | ! align="center" style="background:#DCDCDC;" |[[Lichen simplex chronicus|Lichen simplex]] <ref name="pmid28785363">{{cite journal |vauthors=Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G |title=Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade |journal=Open Access Maced J Med Sci |volume=5 |issue=4 |pages=556–557 |date=July 2017 |pmid=28785363 |pmc=5535688 |doi=10.3889/oamjms.2017.133 |url=}}</ref>[[Lichen simplex chronicus|chronicus]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Secondary to extensive [[pruritus]] due to other conditions such as [[Atopic dermatitis|atopic dermatitis,]] neuropathic pruritus, etc | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, peak at 30-50 years of age | | align="center" style="background:#F5F5F5;" |Any, peak at 30-50 years of age | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Multiple | ||
| align="center" style="background:#F5F5F5;" |[[Lichenification|Lichenified]] and [[erythematous]], [[Itch|pruritic]] [[exudative]] [[Plaques|plaque]], and excoriations | |||
| align="center" style="background:#F5F5F5;" |Scalp, head, neck, hands, arms, and genitals areas | |||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | Scalp, head, neck, hands, arms, and genitals areas | |||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Color of plaque varies | *Color of [[Plaques|plaque]] varies from yellow to reddish-brown | ||
* Plaque size can vary between 3X6 cm 6X10 cm areas. | *[[Plaque]] size can vary between 3X6 cm 6X10 cm areas. | ||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | Nl | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Markedly hyperplastic epidermis | *Markedly [[Hyperplasia|hyperplastic]] [[epidermis]] | ||
* Irregular hyperkeratosis and parakeratosis | *Irregular [[hyperkeratosis]] and parakeratosis | ||
* Thick granular zone | *Thick granular zone | ||
* Acanthosis | *[[Acanthosis]] | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" |Risk factors include | ||
* Sexual dysfunction | |||
* Sleep disturbances | *[[Emotional stress]] | ||
* Depression | *Dry weather | ||
*[[Sweating]] | |||
*[[Sexual dysfunction]] | |||
*[[Sleep disturbances]] | |||
*[[Depression]] | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Ichthyosis vulgaris]]<ref name="pmid23301728">{{cite journal |vauthors=Thyssen JP, Godoy-Gijon E, Elias PM |title=Ichthyosis vulgaris: the filaggrin mutation disease |journal=Br. J. Dermatol. |volume=168 |issue=6 |pages=1155–66 |date=June 2013 |pmid=23301728 |doi=10.1111/bjd.12219 |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Ichthyosis vulgaris]]<ref name="pmid23301728">{{cite journal |vauthors=Thyssen JP, Godoy-Gijon E, Elias PM |title=Ichthyosis vulgaris: the filaggrin mutation disease |journal=Br. J. Dermatol. |volume=168 |issue=6 |pages=1155–66 |date=June 2013 |pmid=23301728 |doi=10.1111/bjd.12219 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Loss of function mutations in the filaggrin gene (''FLG'') | *Loss of function [[mutations]] in the [[Filaggrin|filaggrin gene (''FLG'')]] | ||
* Autosomal dominant inheritance with incomplete penetrance | *[[Autosomal dominant inheritance]] with [[incomplete penetrance]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Usually in infancy | | align="center" style="background:#F5F5F5;" |Usually in infancy | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *[[Xerosis]] and gray [[Ichthyosis|scaling]] | ||
* | *[[Palmar]] hyperlinearity | ||
*[[Keratosis pilaris]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*Extensor surfaces of the extremities | |||
*Scalp | |||
*Trunk | |||
| align="center" style="background:#F5F5F5;" |– | |||
* Extensor surfaces of the extremities | | align="center" style="background:#F5F5F5;" |– | ||
* Scalp | | align="center" style="background:#F5F5F5;" |– | ||
* Trunk | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Scales can vary from mild scaling to large, plate (armor)-like scales and thickening of the skin. | *Scales can vary from mild scaling to large, plate (armor)-like scales and thickening of the skin. | ||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | Nl | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Reduced keratohyalin granules | *Reduced keratohyalin [[granules]] | ||
* Perinuclear keratin retractions in granular cells | *[[Perinuclear space|Perinuclear]] [[keratin]] retractions in [[Granule cell|granular]] cells | ||
* Thick stratum corneum | *Thick [[stratum corneum]] | ||
* Basket-weave pattern of stratum corneum | *Basket-weave pattern of [[stratum corneum]] | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Increased risk | *Increased risk of [[atopic diseases]] including [[asthma]], alllergic rhinitis and [[atopic dermatitis]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Nummular dermatitis|Nummular dermatitis (discoid eczema)]] | ! align="center" style="background:#DCDCDC;" |[[Nummular dermatitis|Nummular dermatitis (discoid eczema)]] | ||
| align="center" style="background:#F5F5F5;" | Unknown | | align="center" style="background:#F5F5F5;" |Unknown | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females | | align="center" style="background:#F5F5F5;" |Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Symmetrical coin-shaped [[Erythematous rash|erythematous]] [[plaques]] | ||
* | *Erosions and excoriations | ||
*Chronic lesions- central clearing leading to annular lesions | |||
* | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Upper | *Upper and lower extremities | ||
*Lower trunk | |||
* Lower trunk | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Chronically lesions result into central clearing leading to annular lesions. | *Chronically [[lesions]] result into central clearing leading to annular lesions. | ||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | Nl | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Spongiosis | *Spongiosis | ||
* Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils | *[[Perivascular cell|Perivascular]] [[lymphocytic]] infiltrates, with [[eosinophils]] and occasional [[neutrophils]] | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Superinfection with ''staphylococcus aureus'' | *Risk factors include | ||
**Temperature changes (particularly winter) | |||
**[[Emotional stress]] | |||
**[[Dry skin]] | |||
**Environmental irritants | |||
**Recent [[surgery]] | |||
**Medications like [[topical]] antibiotic creams and [[isotretinoin]] | |||
*[[Superinfection]] with ''[[staphylococcus aureus]]'' | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Netherton's syndrome]]<ref name="pmid10835624">{{cite journal |vauthors=Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A |title=Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome |journal=Nat. Genet. |volume=25 |issue=2 |pages=141–2 |date=June 2000 |pmid=10835624 |doi=10.1038/75977 |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Netherton's syndrome]]<ref name="pmid10835624">{{cite journal |vauthors=Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A |title=Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome |journal=Nat. Genet. |volume=25 |issue=2 |pages=141–2 |date=June 2000 |pmid=10835624 |doi=10.1038/75977 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | Autosomal recessive mutations in the serine protease inhibitor of Kazal type 5 gene (''SPINK5), encoding LEKTI'', a serine protease inhibitor | | align="center" style="background:#F5F5F5;" |[[Autosomal recessive]] [[mutations]] in the [[SPINK5|serine protease inhibitor of Kazal type 5 gene (''SPINK5)'']]'', encoding [[LEKTI]]''[[LEKTI|, a serine protease inhibitor]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | Affects neonates | | align="center" style="background:#F5F5F5;" |Affects [[neonates]] | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Classic triad | ||
**Congenital ichthyosiform erythroderma | |||
**Trichorrhexis invaginata | |||
**[[Atopy|Allergic diseases]] with ↑ serum [[IgE]] levels | |||
*Ichthyosis linearis circumflexa (ILC) - [[serpiginous]] [[plaques]] with double scale at the margins | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*Diffuse pattern | |||
*Axillae, | |||
*Hair | |||
*Inguinal folds | |||
*Gluteal cleft | |||
*Groin | |||
* Diffuse pattern | *Lower legs | ||
* Axillae, | |||
* Hair | |||
* Inguinal folds | |||
* Gluteal cleft | |||
* Groin | |||
* Lower legs | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Trichorrhexis invaginata (hair involvement): | *Trichorrhexis invaginata (hair involvement): | ||
** Sparse, short, spike and brittle | **Sparse, short, spike and brittle | ||
** "Bamboo hair" or "ball and socket deformity" of hair and eyebrows | **"Bamboo hair" or "ball and socket deformity" of hair and eyebrows | ||
** Nodes along the hair shaft | **Nodes along the hair shaft | ||
| align="center" style="background:#F5F5F5;" |Nl to ↑ | | align="center" style="background:#F5F5F5;" |Nl to ↑ | ||
(Eosinophilia) | ([[Eosinophilia]]) | ||
| align="center" style="background:#F5F5F5;" |↑ | |||
| align="center" style="background:#F5F5F5;" | ↑ | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Psoriasiform [[hyperplasia]] | ||
* Reduced granular layer | *Reduced granular layer | ||
* Dyskeratosis | *Dyskeratosis | ||
* Dermal inflammatory infiltrate including neutrophils and eosinophils | *[[Dermal]] [[inflammatory]] infiltrate including [[neutrophils]] and [[eosinophils]] | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
** Systemic and skin superinfections | *[[Atopic diseases]] including asthma, [[atopic dermatitis]] and [[allergic rhinitis]] | ||
* | *Systemic and skin superinfections | ||
*[[Failure to thrive]] | |||
*Electrolyte imbalances, including [[hypernatremia]],[[dehydration]] | |||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
Line 382: | Line 363: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/ | ||
Multiple | Multiple | ||
Line 389: | Line 369: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pustule | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pustule | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
! | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | |||
! align="center" style="background:#DCDCDC;" |[[Molluscum contagiosum]] | ! align="center" style="background:#DCDCDC;" |[[Molluscum contagiosum]] | ||
| align="center" style="background:#F5F5F5;" | Molluscum contagiosum virus inoculation through direct skin contact | | align="center" style="background:#F5F5F5;" |[[Molluscum contagiosum]] virus [[inoculation]] through direct skin contact | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, peak among children >5 years of age and young adults | | align="center" style="background:#F5F5F5;" |Any, peak among children >5 years of age and young adults | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Flesh-colored, dome-shaped [[papules]] with a central umbilication | ||
*Lesions are 2-5mm in diameter | |||
* | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*Face, trunk, [[Antecubital fossa|antecubital]], [[Popliteal fossa|popliteal fossae]] and groin | |||
| align="center" style="background:#F5F5F5;" |– | |||
* Face, trunk, antecubital, popliteal fossae and groin | |||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |If [[molluscum contagiosum]] is acquired as [[sexually transmitted disease]], it involves, groin and genital region. | ||
| align="center" style="background:#F5F5F5;" | If molluscum contagiosum is acquired as sexually transmitted disease, it involves, groin and genital region. | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | Nl | |||
| align="center" style="background:#F5F5F5;" | Nl | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies) | *[[Keratinocytes]] containing [[eosinophilic]] [[inclusion bodies]] (Henderson-Paterson bodies) | ||
* H&E stain - inwards indentation of the epidermis | *[[H&E stain]] - inwards indentation of the [[epidermis]] | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
*Often [[asymptomatic]] | |||
lesions on the eyelid may lead to follicular or papillary | *Self resolve within 2 months | ||
*Immunodeficient patients present with extensive and severe infections | |||
*[[Molluscum contagiosum]] lesions on the [[eyelid]] may lead to follicular or papillary [[conjunctivitis]] | |||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders | ||
! align="center" style="background:#DCDCDC;" |[[Dermatitis herpetiformis]]<ref name="pmid22137227">{{cite journal |vauthors=Kárpáti S |title=Dermatitis herpetiformis |journal=Clin. Dermatol. |volume=30 |issue=1 |pages=56–9 |date=2012 |pmid=22137227 |doi=10.1016/j.clindermatol.2011.03.010 |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Dermatitis herpetiformis]]<ref name="pmid22137227">{{cite journal |vauthors=Kárpáti S |title=Dermatitis herpetiformis |journal=Clin. Dermatol. |volume=30 |issue=1 |pages=56–9 |date=2012 |pmid=22137227 |doi=10.1016/j.clindermatol.2011.03.010 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | Autoimmune disorder as a result of gluten sensitivity leading to the formation of IgA antibodies | | align="center" style="background:#F5F5F5;" |[[Autoimmunity|Autoimmune]] disorder as a result of [[gluten sensitivity]] leading to the formation of [[IgA]] antibodies | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Any, mean age of disease onset is 2nd-4th decade | | align="center" style="background:#F5F5F5;" |Any, mean age of disease onset is 2nd-4th decade | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Excoriated [[papules]], [[plaques]] and [[vesicles]] arranged in a clustered fashion | ||
* | *Symmetrical | ||
*Erosions and excoriations | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*Extensor surfaces including arms, knees, and buttocks. | |||
| align="center" style="background:#F5F5F5;" |– | |||
* Extensor surfaces including arms, knees, and buttocks. | |||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Oral manifestation such as vesicles and erosion may be present | *Oral manifestation such as [[vesicles]] and erosion may be present | ||
| align="center" style="background:#F5F5F5;" |Nl | |||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | Nl | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Papillary micro-abscesses | *[[Papillary]] micro-[[abscesses]] | ||
* Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin | *Sub-epidermal [[blisters]] containing [[neutrophils]], [[eosinophils]], and [[fibrin]] | ||
* Sub-epidermal vacuolization | *Sub-epidermal [[vacuolization]] | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Abdominal bloating, pain, diarrhea, or constipation | *Intermittent [[Itch|pruritic]] [[papules]] and [[vesicles]] | ||
*[[Celiac disease]] with [[Villous folds|villous]] atrophy and [[Crypt (anatomy)|crypt]] [[hyperplasia]] | |||
*Abdominal [[bloating]], pain, [[Diarrheal|diarrhea]], or [[constipation]] | |||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Wiskott-Aldrich syndrome]]<ref name="pmid24817816">{{cite journal |vauthors=Buchbinder D, Nugent DJ, Fillipovich AH |title=Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments |journal=Appl Clin Genet |volume=7 |issue= |pages=55–66 |date=2014 |pmid=24817816 |pmc=4012343 |doi=10.2147/TACG.S58444 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Wiskott-Aldrich syndrome]]<ref name="pmid24817816">{{cite journal |vauthors=Buchbinder D, Nugent DJ, Fillipovich AH |title=Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments |journal=Appl Clin Genet |volume=7 |issue= |pages=55–66 |date=2014 |pmid=24817816 |pmc=4012343 |doi=10.2147/TACG.S58444 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Mutation in the gene encoding for Wiskott-Aldrich syndrome protein (WASp) on the short arm of the X chromosome | *Mutation in the gene encoding for [[Wiskott-Aldrich syndrome]] protein (WASp) on the short arm of the [[X chromosome]] | ||
* X-linked disorder | *[[X linked inheritance|X-linked disorder]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | Seen almost exclusively in males in infancy | | align="center" style="background:#F5F5F5;" |Seen almost exclusively in males in infancy | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*Rash is clinically similar to [[atopic dermatitis]] | |||
*[[Erythematous]] and [[Itch|pruritic]] lesions | |||
*Lesions can bleed due to [[thrombocytopenia]] | |||
*Cutaneous manifestations includes [[Petechia|petechiae]] and [[ecchymosis]] | |||
| align="center" style="background:#F5F5F5;" |Rash can involve lesions located at the same areas of classical atopic dermatitis: | |||
* Rash is clinically similar to atopic dermatitis | |||
* Erythematous and pruritic lesions | |||
* Lesions can bleed due to thrombocytopenia | |||
* Cutaneous manifestations includes petechiae and ecchymosis | |||
| align="center" style="background:#F5F5F5;" | Rash can involve lesions located at the same areas of classical atopic dermatitis: | |||
extensor surfaces of extremities and cheeks or scalp | extensor surfaces of extremities and cheeks or scalp | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |Infants can present with [[petechiae]], prolonged [[bleeding]] from [[umbilicus]] or circumcision, [[purpura]],[[hematemesis]], [[melena]], [[epistaxis]], [[hematuria]] or unusal bruising | ||
| align="center" style="background:#F5F5F5;" | Infants can present with petechiae, prolonged bleeding from umbilicus or circumcision, purpura, hematemesis, melena, epistaxis, hematuria or unusal bruising | |||
| align="center" style="background:#F5F5F5;" |Nl to ↑ | | align="center" style="background:#F5F5F5;" |Nl to ↑ | ||
(Eosinophilia) | ([[Eosinophilia]]) | ||
| align="center" style="background:#F5F5F5;" |↑ | |||
| align="center" style="background:#F5F5F5;" | ↑ | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Hyperkeratosis]] | *[[Hyperkeratosis]] | ||
* Psoriasiform hyperplasia | *Psoriasiform [[hyperplasia]] | ||
* Dyskeratosis | *Dyskeratosis | ||
* Epidermal psoriasiform [[hyperplasia]] | *Epidermal psoriasiform [[hyperplasia]] | ||
* Marked intercellular [[edema]] with spongiotic vesiculation | *Marked intercellular [[edema]] with spongiotic vesiculation | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* ↑ serum | *↑ serum [[IgA]] levels | ||
* ↑ serum | *↑ serum [[IgE]] levels | ||
*Bleeding: severe [[thrombocytopenia]], | |||
*[[Eczema]] - similar to [[atopic dermatitis]] | |||
*Recurrent sino-pulmonary infections | |||
*[[Opportunistic infection|Opportunistic infections.]] | |||
*[[Autoimmune diseases]] | |||
*[[Malignancies]] | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hyper-IgE syndrome]]<ref name="pmid24058807">{{cite journal |vauthors=Mogensen TH |title=STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties |journal=JAKSTAT |volume=2 |issue=2 |pages=e23435 |date=April 2013 |pmid=24058807 |pmc=3710320 |doi=10.4161/jkst.23435 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hyper-IgE syndrome]]<ref name="pmid24058807">{{cite journal |vauthors=Mogensen TH |title=STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties |journal=JAKSTAT |volume=2 |issue=2 |pages=e23435 |date=April 2013 |pmid=24058807 |pmc=3710320 |doi=10.4161/jkst.23435 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Defects in the JAK-STAT signaling pathway leading to dysfunctional T helper cell type 17 (Th17) differentiation | *Defects in the [[JAK-STAT signaling pathway]] leading to dysfunctional [[T helper cell]] type 17 ([[T helper 17 cell|Th17]]) [[differentiation]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | Rare, begin in infancy | | align="center" style="background:#F5F5F5;" |Rare, begin in infancy | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Papulopustular | *Papulopustular | ||
* Severely pruritic eczematous rash | *Severely [[Itch|pruritic]] eczematous rash | ||
* Pustular and may impetiginized | *[[Pustular rash|Pustular]] and may impetiginized | ||
* Lichenification may occur | *[[Lichenification]] may occur | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Face and scalp | *Face and scalp | ||
* Upper trunk and shoulders | *Upper trunk and shoulders | ||
* Buttocks | *Buttocks | ||
* Area behind the ears and around the hairline | *Area behind the ears and around the hairline | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Characteristic coarse facies | *Characteristic coarse facies | ||
* Increased alar width and broad nasal bridge | *Increased alar width and broad [[nasal bridge]] | ||
* High-arched oral palate | *High-arched oral palate | ||
* Hyperextensible joints | *Hyperextensible joints | ||
| align="center" style="background:#F5F5F5;" |Nl to ↑ | | align="center" style="background:#F5F5F5;" |Nl to ↑ | ||
(Eosinophilia) | ([[Eosinophilia]]) | ||
| align="center" style="background:#F5F5F5;" |↑ | |||
| align="center" style="background:#F5F5F5;" | ↑ | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Eosinophil-rich infiltration around the hair follicles | *[[Eosinophil]]-rich infiltration around the hair follicles | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* | *Cold [[abscesses]] | ||
*[[Itch|Pruritic]] [[eczema]] | |||
*[[Allergy|Allergic]] diseases | |||
*Noneruption of permanent teeth | |||
*Multiple bone [[Bone fracture|fractures]] and scoliosisis | |||
*[[Peripheral T-cell lymphomas|Peripheral T-cell lymphoma]] | |||
*[[Coronary artery]] [[aneurysms]] | |||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mycosis fungoides]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mycosis fungoides]] | ||
| align="center" style="background:#F5F5F5;" | Clonal expansion of CD4<sup>+</sup> memory T cells (CD45RO<sup>+</sup>) | | align="center" style="background:#F5F5F5;" |Clonal expansion of [[CD4+ cell|CD4]]<sup>+</sup> [[memory T cells]] (CD45RO<sup>+</sup>) | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | Mean age is 55- 60 years | | align="center" style="background:#F5F5F5;" |Mean age is 55- 60 years | ||
| align="center" style="background:#F5F5F5;" |Multiple | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Non-pruritic patches and intensely [[Itch|pruritic]] [[plaques]] | ||
** | *[[Comedones]], [[cysts]] | ||
** | *[[Tumors]] of skin | ||
*[[Erythematous]] [[macules]] | |||
*[[Hypopigmented area|Hypopigmented]] patches | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
*Asymmetrical | |||
*Hips, groin and trunk | |||
| align="center" style="background:#F5F5F5;" |– | |||
* Asymmetrical | |||
* Hips, groin and trunk | |||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | |||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | – | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Alopecia | *[[Alopecia]] | ||
* Acneiform lesions | *[[Acneiform eruption|Acneiform]] lesions | ||
* Plaques size can vary between 2-20 cm | *[[Plaques]] size can vary between 2-20 cm | ||
* Lymphadenopathy | *[[Lymphadenopathy]] | ||
* Children- hypopigmented patches most common | *Children- [[Hypopigmentation|hypopigmented]] patches most common | ||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* | *Perifollicular infiltrates around the [[infundibulum]] | ||
* | *[[Epidermis]] is spared or has minimal spongiosis | ||
*Band-like [[Dermal|derma]]<nowiki/>l infiltrate of [[lymphocytes]] and and [[histiocytes]] | |||
| colspan="2" align="center" style="background:#F5F5F5;" | | |||
*Increased risk of : | |||
**Severe viral and bacterial infections | |||
* | **Secondary [[malignancies]], especially lymphomas | ||
*Staging of [[Mycosis fungoides]] is based upon: | |||
**Patches | |||
**[[Plaques]] | |||
**Skin tumors | |||
**[[Lymphadenopathy]] | |||
**[[Erythroderma]] | |||
**[[Histology]] | |||
|} | |} | ||
Line 701: | Line 571: | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Latest revision as of 02:44, 16 October 2021
Atopic dermatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Atopic dermatitis differential diagnosis On the Web |
American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis |
Risk calculators and risk factors forAtopic dermatitis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogechukwu Hannah Nnabude, MD; Shalinder Singh, M.B.B.S.[2]
Overview
Atopic dermatitis is a chronic inflammatory skin disorder, which is indistinguishable from other causes of dermatitis. Atopic dermatitis is usually associated with personal or family history of atopic diseases including asthma, allergic rhinitis and food allergy. The most common clinically similar dermatitis in infancy is seborrheic dermatitis which includes hyperkeratosis of the scalp, also found in atopic dermatitis.
Atopic Dermatitis from other Diseases
Atopic dermatitis should be differentiated from allergic contact dermatitis, iirritant contact dermatitis, seborrheic dermatitis, psoriasis, lichen simplex chronicus, ichthyosis vulgaris, nummular dermatitis (discoid eczema), netherton's syndrome, and dermatitis herpetiformis
Category | Diseases | Etiology | Inherited | Acquired | Clinical manifestations | Para-clinical findings | Associated factors | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | Symptoms | Physical examination | ||||||||||||||||
Lab Findings | Histopathology | |||||||||||||||||
Appearance | Itching | Fever | Tenderness | Other | Eosinophils | Serum IgE | ||||||||||||
Single/
Multiple |
Rash | Involved areas | Pustule | |||||||||||||||
Skin disorders | Atopic dermatitis |
|
+ | + | Multiple |
|
– | + | – | – |
|
Nl to ↑ | ↑ |
|
| |||
Allergic contact dermatitis[1] |
|
– | + | Any | May be multiple after 1-2 days of exposure | Erythematous well-demarcated papules | Surrounding the area in contact with the offending agent | – | + | – | + |
|
Nl to ↑ | Nl |
|
| ||
Irritant contact dermatitis[2] |
|
– | + | Any, more with occupational exposure | Usually single immediately after the exposure | Well-demarcated red patch with a glazed surface | Any area in contact with the irritant | – | + | – | + |
|
Nl | Nl |
|
| ||
Seborrheic dermatitis |
|
– | + | Any, onset during the infancy and peak during 3rd-4th decades | Multiple |
|
Scalp, face, trunk, postauricular, diaper area and axilla | + | + | – | – |
|
Nl | Nl |
|
Risk factors include
Generalized seborrheic erythroderma in immunodeficient patients | ||
Psoriasis |
|
+ | + | Any, 2 peaks of onset 30-39 years and 50-59 years | Multiple | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales |
|
+ | + | _ | + |
|
Nl | Nl |
|
Risk factors include
| ||
Lichen simplex [3]chronicus |
|
– | + | Any, peak at 30-50 years of age | Multiple | Lichenified and erythematous, pruritic exudative plaque, and excoriations | Scalp, head, neck, hands, arms, and genitals areas | – | + | – | – | Nl | Nl |
|
Risk factors include | |||
Ichthyosis vulgaris[4] |
|
+ | + | Usually in infancy | Multiple |
|
|
– | – | – | – |
|
Nl | Nl |
|
| ||
Nummular dermatitis (discoid eczema) | Unknown | – | + | Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females | Multiple |
|
|
– | + | – | – |
|
Nl | Nl |
|
| ||
Netherton's syndrome[5] | Autosomal recessive mutations in the serine protease inhibitor of Kazal type 5 gene (SPINK5), encoding LEKTI, a serine protease inhibitor | + | – | Affects neonates | Multiple |
|
|
+ | + | – | – |
|
Nl to ↑ | ↑ |
|
| ||
Diseases | Etiology | Inherited | Acquired | Demography | Single/
Multiple |
Rash | Involved areas | Pustule | Itching | Fever | Tenderness | Other | WBC | Serum IgE | Histopathology | Associated factors | ||
Infection | Molluscum contagiosum | Molluscum contagiosum virus inoculation through direct skin contact | – | + | Any, peak among children >5 years of age and young adults | Multiple |
|
|
– | + | – | – | If molluscum contagiosum is acquired as sexually transmitted disease, it involves, groin and genital region. | Nl | Nl |
|
| |
Immunologic disorders | Dermatitis herpetiformis[6] | Autoimmune disorder as a result of gluten sensitivity leading to the formation of IgA antibodies | – | + | Any, mean age of disease onset is 2nd-4th decade | Multiple |
|
– | + | – | – |
|
Nl | Nl |
|
| ||
Immune deficiency | Wiskott-Aldrich syndrome[7] |
|
+ | – | Seen almost exclusively in males in infancy | Multiple |
|
Rash can involve lesions located at the same areas of classical atopic dermatitis:
extensor surfaces of extremities and cheeks or scalp |
– | + | – | – | Infants can present with petechiae, prolonged bleeding from umbilicus or circumcision, purpura,hematemesis, melena, epistaxis, hematuria or unusal bruising | Nl to ↑ | ↑ |
|
| |
Hyper-IgE syndrome[8] |
|
+ | – | Rare, begin in infancy | Multiple |
|
|
+ | + | – | – |
|
Nl to ↑ | ↑ |
|
| ||
Malignancy | Mycosis fungoides | Clonal expansion of CD4+ memory T cells (CD45RO+) | – | + | Mean age is 55- 60 years | Multiple |
|
|
– | + | – | – |
|
Nl | Nl |
|
|
References
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.
- ↑ Bains SN, Nash P, Fonacier L (October 2018). "Irritant Contact Dermatitis". Clin Rev Allergy Immunol. doi:10.1007/s12016-018-8713-0. PMID 30293200.
- ↑ Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G (July 2017). "Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade". Open Access Maced J Med Sci. 5 (4): 556–557. doi:10.3889/oamjms.2017.133. PMC 5535688. PMID 28785363.
- ↑ Thyssen JP, Godoy-Gijon E, Elias PM (June 2013). "Ichthyosis vulgaris: the filaggrin mutation disease". Br. J. Dermatol. 168 (6): 1155–66. doi:10.1111/bjd.12219. PMID 23301728.
- ↑ Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A (June 2000). "Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome". Nat. Genet. 25 (2): 141–2. doi:10.1038/75977. PMID 10835624.
- ↑ Kárpáti S (2012). "Dermatitis herpetiformis". Clin. Dermatol. 30 (1): 56–9. doi:10.1016/j.clindermatol.2011.03.010. PMID 22137227.
- ↑ Buchbinder D, Nugent DJ, Fillipovich AH (2014). "Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments". Appl Clin Genet. 7: 55–66. doi:10.2147/TACG.S58444. PMC 4012343. PMID 24817816.
- ↑ Mogensen TH (April 2013). "STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties". JAKSTAT. 2 (2): e23435. doi:10.4161/jkst.23435. PMC 3710320. PMID 24058807.